MTOR and lung carcinoma: mEAK-7 is significantly elevated in the tumors and metastatic lymph nodes of NSCLC patients, and microRNA-1911-3p can target mEAK-7 to inhibit mTOR signaling in human lung cancer cells (43, 44).